Risk-sharing agreements (RSAs), especially performance-based, are only growing in popularity among payers, health technology assessment (HTA) agencies...
Risks and Solutions for High-cost Therapies In the last few years, we have seen novel therapies for some complex, rare, and even previously untreatabl...
Introduction A major challenge around recruitment and retention of subjects in clinical trials has been the requirement for them to have easy access t...
Value-based healthcare (VBH) as a concept was introduced in 2006 by Porter and Teisberg1, though facets of this concept have been around for much long...
Actu-Real Inc. and Jehangir Clinical Dev Centre (JCDC) announce their joint initiative J-ARC Healthcare Solutions, a strategic collaboration to furthe...
Leveraging real-world evidence in clinical development Commentary on the MHRA guidance on the use of real-world data in clinical studies to support re...
Value based healthcare can only make an impact if it can address complicated concerns such as marginal benefits to healthcare, comparative net health...
There have been many reactions to the retrospective study identifying sildenafil (Viagra) as a candidate drug for Alzheimer’s disease that has just be...
A recent article in the November 24 issue of Fierce Healthcare summarizes results from value-based care from the insurer Humana in their latest annual...
Find Us on Social Platforms